A series of new cyanopyridine–triazine hybrids were developed as persuasive multifunctional anti-AD agents.
Docking studies were performed on reported crystal structures of human acetylcholinesterase and butyrylcholinesterase.
In vitro inhibitory potencies against acetylcholinesterase, and butyrylcholinesterase were assessed.
20">Aβ1–42 disaggregation, oxygen radical absorbance, cytotoxicity, neuroprotection tests were also performed.